Phathom Pharmaceuticals: CFO Sanjeev Narula sold 13,485 shares

What happened

• Sanjeev Narula, chief financial officer, surrendered 13,485 shares at $6.78 per share on Oct 6, 2026, resulting in $91,428. The filing lists the transaction code as F (payment of exercise price or tax liability).

Key details

• Transaction date and price: Oct 6, 2026 — 13,485 shares at $6.78 per share; total $91,428.
• Filing date and report period: filed Oct 8, 2026; period of report Oct 6, 2026.
• Shares owned after the transaction: not stated in the filing.
• Relevant footnotes:
  • F1: Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation.
  • F2: Includes 1,488 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2026.
• Filing timeliness: the filing does not indicate it was filed late.

Why it may matter

• Tax withholding: the shares were surrendered to the issuer to satisfy tax withholding (per footnote F1); this was not a market sale to a third party.
• This filing does not show why the insider traded or why the company acted.